14159 capital (GP), LLC Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
14159 capital (GP), LLC in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of 14159 capital (GP), LLC: Director
Holdings: 323,148 shares
Current Value: $19,644,167
Latest Transaction: Sep 08 2011
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of 14159 capital (GP), LLC in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, GHDX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 17.27 | 271 | 4,680 | 323,148 | 322.9 K to 323.1 K (+0.08 %) |
| Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 17.06 | 1,075 | 18,344 | 322,877 | 321.8 K to 322.9 K (+0.33 %) |
| Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 17.00 | 427 | 7,261 | 321,802 | 321.4 K to 321.8 K (+0.13 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.35 | 135 | 2,072 | 321,375 | 321.2 K to 321.4 K (+0.04 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.53 | 7,228 | 112,244 | 321,240 | 314 K to 321.2 K (+2.30 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.45 | 7,787 | 120,334 | 314,012 | 306.2 K to 314 K (+2.54 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.98 | 52 | 779 | 306,225 | 306.2 K to 306.2 K (+0.02 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.98 | 95 | 1,423 | 306,173 | 306.1 K to 306.2 K (+0.03 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.79 | 2,562 | 37,892 | 306,078 | 303.5 K to 306.1 K (+0.84 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.60 | 67 | 978 | 303,516 | 303.4 K to 303.5 K (+0.02 %) |
Page: 1